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Background: Gastrointestinal nematodes are an important cause of reduced performance in cattle. Previous studies
in Europe showed that after anthelmintic treatment an average gain in milk production of around 1 kg per day/
cow can be expected. However, (1) these studies have mainly evaluated group-based anthelmintic treatments during
the grazing season or at housing and (2) little is known about parameters affecting variations in the treatment response
amongst cows. A better knowledge of such parameters could help to select animals that benefit most from treatment
and thus lead to a more rational use of anthelmintics. Therefore, a randomized, non-blinded, controlled clinical trial was
performed on 11 commercial dairy farms (477 animals) in Belgium, aiming (1) to study the effect of eprinomectin
treatment at calving on milk production and (2) to investigate whether the milk yield response was related to
non-invasive animal parameters such that these could be used to inform targeted selective treatment decisions.
Results: Analyses show that eprinomectin treatment around calving resulted in an average (± standard error) increase
of 0.97 (±0.41) kg in daily milk yield that was followed up over 274 days on average. Milk yield responses were higher
in multiparous compared to primiparous cows and in cows with a high (4th quartile) anti-O. ostertagi antibody level in a
milk sample from the previous lactation. Nonetheless, high responses were also seen in animals with a low (1st quartile)
anti-O. ostertagi antibody level. In addition, positive treatment responses were associated with higher faecal egg counts
and a moderate body condition score at calving (2nd quartile).
Conclusions: In conclusion, this study provides novel insights into the production response after anthelmintic
treatment at calving and factors which influence this. The data could be used to support the development of
evidence-based targeted selective anthelmintic treatment strategies in dairy cattle.
Keywords: Dairy cattle, Gastrointestinal nematodes, Targeted selective treatment, Anti-O. ostertagi antibody level,
Faecal egg counts, EprinomectinBackground
Gastrointestinal nematodes (GI) are an important cause of
reduced performance in grazing cattle. A review of studies
on the effect of anthelmintic treatment on milk production
from 2000 onwards reported an average milk yield response
of 1 kg/cow per day [1]. At present, two innovative con-
cepts are described to prevent nematode-associated pro-
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unless otherwise stated.namely targeted treatment (TT) and target selective treat-
ment (TST) [2]. Using TT, the whole group or herd is
treated at an optimal time based on parameters that quan-
tify the risk of infection and/or production losses. A useful
parameter currently available for TT in adult dairy cattle is
the anti-O. ostertagi antibody level in milk [3]. When apply-
ing TST, only selected individuals are treated, the aim being
to lower the risk for the development of anthelmintic resist-
ance by increasing the size of the parasite population in re-
fugia. However, practical implementation of TST at the
farm level is still limited by the lack of data on which indi-
cators are useful to identify animals that would benefit mostral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ating the effect of anthelmintic treatment on milk produc-
tion can be considered as TT, as they target whole herds,
and have been restricted to mid-season or housing treat-
ments [4-8]. However, a cost-benefit analysis suggested that
the economic benefit of anthelmintic treatment of dairy
cows is considerably larger when cows are treated around
calving compared to treatment at housing [9]. Studies
assessing the effect of anthelmintic treatment around
calving have been carried out in Canada [10-12] and New
Zealand [13], but significant differences in climate and farm
management practices may result in different parasite epi-
demiology and different production effects when compared
to European circumstances.
Most clinical trials evaluating the effect of anthelmin-
tic treatment, report the average effect in the study
population. It is well recognized that treatment re-
sponses can vary largely within and amongst herds [14]
and depend on factors such as infection level and man-
agement [15]. Less is known about easy-to-use animal
parameters that are potentially related to the within-
herd variation of production responses, or that could act
as a proxy for such responses. A better understanding of
these relationships is key to identifying the animals that
would benefit most from anthelmintic drug administra-
tion, consistent with the TST approach. Previously some
indicators have been associated with the milk yield re-
sponse after anthelmintic treatment. The parameter
yielding most consistent results is the anti-Ostertagia
ostertagi antibody level in individual milk samples, with
studies showing higher treatment responses in cows with
a high antibody level [3,11,12,16]. As for the age of the
cow, some studies found no relationship with treatment
effect [10,14,17], whereas others reported a higher milk
yield gain in older cows [3,13] or conversely, in younger
cows [5]. Finally, it was suggested that treatment re-
sponses were higher in high producing animals [14,18],
but this was not observed by others [10].
A problem associated with previous studies is that
mostly the study design was aimed at investigating the
overall treatment effect, leading to low statistical power or
unbalanced data for evaluating the effect of indicators
associated with the treatment response. Therefore, we per-
formed a randomized, non-blinded, controlled clinical trial
with herd (< vs. > average herd production level), O. oster-
tagi-antibody levels in individual milk samples (optical
density ratio (ODR) < vs. ≥0.5) and age (2nd vs. ≥3rd lacta-
tion) as blocking factors for treatment assignment. The
aim were (1) to investigate the effect of anthelmintic treat-
ment at calving on milk production in dairy cattle and (2)
to evaluate if some easy-to-use animal parameters (i.e. par-
ity, body condition score, pre-treatment anti-O. ostertagi
antibody levels) are associated with the milk production
response following anthelmintic treatment.Methods
Following the recommendations of Belgian and European
legislation (KB 11/5/2007; 86/609/EEC), this field study
conducted on commercial dairy herds did not require eth-
ical approval.Selection of farms
The study was conducted on 11 dairy herds located in
Flanders, Belgium. On average 73 lactating animals, mainly
Holstein Friesians, were present on these farms, while the
rolling herd average ranged between 7262 and 10920 kg
milk. Cows calved all year round. The following criteria
were applied for the selection of farms: (1) cows had previ-
ous access to pasture and were naturally infected with
gastrointestinal nematodes (i.e. anti-O. ostertagi ELISA re-
sults on bulk milk samples of April 2011 ≥ 0.6 ODR), (2)
the last treatment of the cows against GI nematodes had
been performed ≥6 months before the experimental treat-
ment and (3) participation in the milk production registra-
tion program of CRV (Arnhem, The Netherlands) to enable
standardized data collection.Study design
A non-blinded, randomized, controlled clinical trial was
performed to evaluate the effect of anthelmintic treat-
ment at calving on milk production and to evaluate the
association with easy-to-use indicators. Both first-calving
heifers and older animals were included in the trial.
Within 15 days after calving the animals either received
treatment with eprinomectin (Eprinex® pour-on, Merial)
at a dosage of 0.1 ml per kg bodyweight (500 μg/kg) or
received no treatment. Treatments were performed by
the farmer, based on the estimated bodyweight. The cap-
ability of the participating farmers to estimate the body
weight of their animals was tested during farm visits on
which the body weight of several random animals was
measured based on the heart girth. These measurements
revealed that when body weights were underestimated
the underestimations were generally low (<50 kg).
The multiparous cows were randomly assigned within
herd using O. ostertagi antibody level in individual milk
sample measured in April 2011 (< vs. ≥0.5 ODR), cow
parity (2nd vs. ≥3rd lactation) and previous production level
(< vs. > herd-average) as blocking factors. The treatment
assignments were communicated to the farmer through a
hard-copy attention list, generated with the aid of the herd
management software (Veemanager, CRV, Arnhem, The
Netherlands) and specifying cow identification, expected
calving date and the randomly assigned group (treatment
or no treatment).
Due to the lack of an ODR measurement from the pre-
vious lactation, heifers could not be included in the ran-
domized list. Therefore, the farmer was asked to alternate
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following the order in which they calved.
The farmer was requested to complete the hard-copy
attention list at the time of treatment by noting the body
condition score (BCS; according to [19]), the estimated
body weight, dosage applied and the date of treatment.
A scale from 1 to 5 was used for the body condition
scoring, where 1 stands for severe under-conditioned
and 5 for severe over-conditioned. At the start of the
trial all farmers received a body condition scoring chart
based on Edmonson et al. [19], as a visual aid.
It is acknowledged that the use of anthelmintic pour-
on treatments in individual cattle potentially com-
promises the precision of delivery of the recommended
dosage to the intended animal and may result in sub-
optimal dosing to in-contact animals too [20]. Therefore,
farmers were advised to prevent close contact between
treated and untreated animals in the first hours follow-
ing treatment. Most did this by treating animals in a
separate calving box several hours before allowing them
to rejoin the lactating animals. This is an important lo-
gistical consideration if TST is to be practised on com-
mercial farms, because this is an inevitable compromise
as it is generally impractical to keep recently treated and
untreated cattle apart for adequate periods.
All concomitant anthelmintic and ectoparasiticide
treatments, other than those defined in the study proto-
col were documented, so that these animals could be ex-
cluded from the analysis. Cattle were enrolled from July
2011 until September 2012. The progress and compli-
ance with the study protocol was monitored through
monthly telephone contacts and three farm visits during
the study period.
Collection of faecal samples and faecal egg counts
On two of the 11 dairy herds, the farmers took faecal
samples at the moment of treatment and these were
stored in a refrigerator until collection on a weekly basis.
Samples were processed immediately after arrival at the
lab and examined for nematode eggs by the FLOTAC®
method based on the manufacturer’s instructions. A sat-
urated sucrose-salt solution was used as flotation solu-
tion (density 1.27) and the suspension was distributed
over one chamber (1 × 5 ml), resulting in an analytic
sensitivity of 2 eggs per gram faeces (EPG; [21]).
Collection of milk samples and O. ostertagi milk ELISA
Bulk tank milk samples were collected at monthly intervals
from July 2011 until July 2012. For logistical reasons, bulk
milk data for the month of April 2012 were not available.
Individual milk samples from all lactating animals were
collected at three-monthly intervals starting from July
2011 until July 2012 as part of routine sampling for quality
control and milk production registration, in cooperationwith the Milk Control Centre, Flanders (MCC, Lier,
Belgium) and CRV (Arnhem, The Netherlands).
The collected milk samples were subjected to a
commercially available antibody-detection O. ostertagi
ELISA (SVANOVIR®O. ostertagi-Ab, Boehringer Ingelheim
Svanova, Uppsala) according to the manufacturer’s in-
structions, at the laboratories of the MCC. The results
were expressed as an optical density ratio (ODR) that is
calculated following the formula ODR = (OD - NC)/(PC -
NC), where OD is the result of the optical density reading
of the sample at 405 nm, and NC and PC are the OD of
the negative and positive control samples, respectively.
Collection of milk production data and processing
Individual milk production records were collected from
the CRV milk recording program, with a 4 to 6 week sam-
pling interval; the parameters used were: kg milk, somatic
cell count (SCC)/1000, breed, days in milk and lactation
number. The milk production records were also subjected
to the MilkBot® lactation model (DairySight LLC, Argyle,
New York) to create a lactation curve [22]. Both the shape
and magnitude of the lactation curve are quantified by the
model as a set of parameter values, each of which is asso-
ciated with a single aspect of lactation curve shape. Ana-
lysis of the Milkbot® parameters allows the detection of
changes in the distribution of milk production that are not
apparent when only daily milk weights or totals are ana-
lyzed. The parameter “scale” is a measure of magnitude,
without changing the shape of the curve. The parameter
“ramp” measures the steepness of the post-parturient rise
in production. The parameter “decay” is used to measure
the rate of decline in production after the peak in milk
production.
Statistical data-analysis
The effect of eprinomectin treatment on the anti-O.
ostertagi antibody levels was analysed through a linear
mixed model with herd and cow nested in herd as ran-
dom effects. Treatment (yes/no), days after treatment,
the month at which the milk was tested and an inter-
action term between treatment and days after treatment
were used as fixed effects in the model. Because the
herds were sampled at 3-monthly intervals, the variable
‘days after treatment’ was categorized in 3 intervals: ‘0–3
months’, ‘3–6 months’, ‘>6 months’. To investigate the
correlation between the faecal egg counts, measured
around the moment of calving, and the anti-O. ostertagi
antibody level, measured in individual milk samples
within 30 days post calving, the Spearman rank correl-
ation coefficient was used.
The effect of eprinomectin treatment on milk produc-
tion parameters was first analysed through a linear
mixed model with the test day milk production (kg milk)
as outcome variable and herd and cow nested in herd as
Table 1 Number of cows, average ± standard deviation of
anti-O. ostertagi antibody levels in individual milk before
treatment registration and distribution of breed,
lactation number and year quarter of calving in the
treated and untreated group
Parameter Eprinomectin Control
Number of cows 234 243
Anti-O. ostertagi antibody level (ODR) 0.49 ± 0.3 0.52 ± 0.3
Breed (%):





Third or higher 26 22
Year quarter:
Jan - Mar 10 14
Apr - Jun 13 8
Jul - Sep 13 12
Oct - Dec 15 15
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(‘1st’, ‘2nd’, ‘3rd or higher’), the natural logarithm of SCC/
1000, number of days in milk (dim), wilmink’s function
(dim-0.05) and year quarter in which calving occurred,
were introduced as fixed effects in the model.
In order to investigate between-herd variation in treat-
ment responses, the analysis was repeated for each herd
separately. Results were presented by a forest plot and
an overall treatment effect was obtained by the precision
weighted average, using a random effects model with
herd as the random effect.
The relationship between the indicators and the milk
production response after treatment was evaluated using
the model mentioned above. Linear interaction terms
were evaluated between the indicators and treatment
effect. These interaction terms were not significant
(α =0.05), except for faecal egg counts. Non-linear ef-
fects were explored by categorizing the data. Continuous
parameters (anti-O. ostertagi antibody level and BCS
centered to the herd mean) were categorized according
to their quartiles. The moment of treatment was catego-
rized in housing (November until March) and pasture
period (April until October) based on Bennema et al.
[23]. When several pre-treatment O. ostertagi ELISA re-
sults for a cow were available, the result of the sample
closest to calving was used. The treatment effect was es-
timated within each category of the pre-treatment anti-
O. ostertagi antibody level, lactation number, the BCS
centered to the herd mean and season (pasture vs.
housed) in which treatment occurred.
To evaluate heteroscedasticity and the normality of
the residuals, plots of the residuals and predicted values
were performed. All analyses were carried out with the
PROC MIXED or PROC CORR command in the soft-
ware package SAS version 9.3 (SAS institute Inc., Cary,
NC, USA), except for the forest plot and precision
weighted treatment effect, which was computed by the
‘metafor’ package in R (Cran).
Results
Herd characteristics and treatment allocation
Analysis of the effect of treatment on the anti-O. ostertagi
antibody levels was based on data obtained from 498 ani-
mals present in the participating herds. The data used to
analyse the effect of treatment on milk production, were
based on 477 cows from all participating herds. Of these,
234 belonged to the treatment group and 243 to the con-
trol group. The treatment response on the test day milk
production records was followed up during 274 days of
lactation on average. Table 1 shows that the average anti-
O. ostertagi antibody level of individual milk samples be-
fore treatment of both groups, lactation number, breed
and the year quarter in which calving occurred were
evenly distributed between the treated and untreatedanimals indicating a successful treatment allocation. Con-
comitant treatments were recorded on 3 of the participat-
ing herds, for a total of 39 animals. All these treatments
were related to liver fluke infections and the anthelmintics
used were either closantel or oxyclozanide, neither of
which has any activity against O. ostertagi.Parasitological parameters
Figure 1a shows the course of the anti-O. ostertagi anti-
body levels recorded in bulk-tank and individual milk
samples during the study period. Figure 1b shows the
course of the anti-O. ostertagi antibody levels in individual
milk samples relative to the month of treatment. In both
the treated and untreated group, antibody levels decreased
after calving. However, there was a significant interaction
(P = 0.02) between treatment and the time variable “month
after treatment” indicating that antibody levels dropped
quicker and remained low for a longer period in treated
compared to untreated animals (Figure 1b). The propor-
tion of the total variation in anti-O. ostertagi antibody
levels that resided at the herd, cow and residual level was
12, 52% and 36%, respectively.
Table 2 lists the faecal egg count results of the two
studied herds. The EPG of trichostrongyle-type eggs
was, on average (± standard error) 26 (±42) and 13
(±29), for the two herds, respectively. The Spearman
rank correlation coefficient between FEC and anti-O.
ostertagi antibody level of individual milk samples taken
within 30 days post calving was R = 0.42 (P = 0.03).
ab
Figure 1 Anti-O. ostertagi antibody levels (ODR) in bulk-tank and individual milk samples during the study period. (a) Course of the
anti-O. ostertagi antibody levels (ODR) during the study period in bulk-tank and individual milk samples on the 11 herds. (b) The course of the
anti-O. ostertagi antibody levels (ODR) relative to the month of calving in individual milk samples of 1274 cows coming from all the 11 herds.
Bars represent standard error of the mean.
Table 2 Results of the faecal egg counts measured
around calving on two dairy herds (N: the number of
samples; P25 and P75: the first and third quartile,
respectively)
Fecal egg count results (EPG)
N Median P25 P75 Range
Herd 1 34 14 2 28 0 - 228
Herd 2 49 2 0 8 0 - 128
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production
Analysis of the treatment response on the test day milk
production records by a linear mixed model showed a sig-
nificant increase of 0.97 (95% confidence interval: 0.17 to
1.77) kg milk/day per cow in eprinomectin treated animals
(P < 0.02; Table 3). The model controlled for the factors
lactation number, somatic cell count, number of days in
milk and the year quarter in which calving occurred. The
herd, cow and residual level explained 27, 35 and 38% of
the total variation, respectively.
The forest plot in Figure 2 shows the variation in
treatment effects between herds. The precision-weighted
Table 3 The results of a linear mixed model to estimate the effect of eprinomectin treatment around calving on daily
milk production in 11 herds (based on 477 cows)
Variable Estimate Lower limit Upper limit t Value P
95% CI 95% CI
Intercept 95.80 88.66 102.93 26.36 <0.001
Eprinomectin (vs. control) 0.97 0.16 1.77 2.36 0.019
Lactation number (baseline is third lactation or higher) <0.001
First −7.15 −8.17 −6.11 −13.66 <0.001
Second −3.05 −4.03 −2.07 −6.13 <0.001
Ln (SCC/1000) −1.21 −1.36 −1.06 −16.12 <0.001
DIM −0.07 −0.07 −0.06 −43.02 <0.001
Wilmink −58.02 −66.05 −49.99 −14.16 <0.001
Year quarter (baseline is 4th year quarter) 0.0064
First −1.23 −2.31 −0.15 −2.23 0.026
Second −1.48 −2.68 −0.27 −2.41 0.016
Third −1.84 −2.94 −0.74 −3.29 0.001
Random Effects Variance S.E. Proportion of total variance (%) Z value P
Herd 12.95 6.00 27 2.16 0.015
Animal 16.50 1.28 35 12.90 <0.001
Residual 17.92 0.44 38 40.48 <0.001
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val: 0.02 to 1.64) kg milk/cow per day.
Although the Milkbot® parameters (scale, ramp, decay)
did not differ significantly between groups, the lactation
curve (Figure 3) suggested that eprinomectin treatment at
calving resulted in a higher peak production and that this
effect was maintained throughout the entire lactation.
The association between non-invasive indicators and the
milk yield response after anthelmintic treatment
An overview of the effect of eprinomectin treatment on
daily milk yield per animal in relation to the evaluated
parameters is provided in Figure 4. Animals in third lac-
tation or higher had a significant increase in daily milk
production after treatment of 1.24 (95% confidence inter-
val: 0.08 to 2.40) kg milk/cow per day. A large and almost
significant effect of 2.05 (95% confidence interval: −0.03 to
4.12) kg milk/cow per day, was also found in the cows in
the 4th quartile of anti-O. ostertagi antibody level pre-
treatment (ODR ≥0.72). A significant treatment effect was
observed in animals with a BCS centered to the herd
mean in the second quartile. The treatment effects were
similar in both seasons. Finally, on the 2 herds where FECs
were performed, a significant linear association was found
between treatment effect and FEC (P = 0.01). This rela-
tionship is illustrated in Figure 5.
Discussion
On commercial dairy farms under European conditions,
anthelmintic treatment administered shortly after calving,resulted in an average increase of 0.97 kg milk/day per
cow. A recent study on anthelmintic treatment at calving
in Canada found a maximal treatment effect of 0.67 kg
milk/day per cow, which is considerably lower than some
of the observations reported here [12]. A study performed
in New Zealand, found a positive effect after treatment in
only one of the three participating herds of 0.78 kg energy
corrected milk/day per cow [24]. Such differences from
our observations underline the need to evaluate treatment
effects on milk production in different geographical loca-
tions and under different management conditions.
Although the treatment was randomly assigned, it was
not blinded to the farmer which could have led to a
biased treatment effect estimate. Non-blinding may re-
sult in occasional use of the anthelmintic product for an-
imals assigned to the control group, however this was
rarely recorded. At the end of the trial, the prescribed
treatment assignment (‘treat’ or ‘not treat’) had not been
followed for a total of 45 animals. The farmer also had
to assess the appropriate dosing based on the estimated
body weight, which is likely to lead to underdosing as
compared to dosing under controlled conditions by the
researcher. Furthermore, there is a higher risk of incor-
rect storage of the anthelmintic product on the farm,
which would also lead to a reduced treatment effect.
Previously, we observed a significant effect of anthel-
mintic treatment at housing on the anti-O. ostertagi
antibody level in bulk milk samples [7]. In that study, no
re-exposure to GI nematodes in the months following
treatment took place and the effect was largest 3–4
RE Model
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Herd Average [95% CI]
Figure 2 Average response in daily milk yield after eprinomectin treatment at calving for each herd separately and the overall inverse
variance weighted average computed with a random effects model. Bars represent the 95% confidence interval.
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served a significant treatment effect on the anti-O. oster-
tagi antibody level in individual milk samples. However,
the anti-O. ostertagi antibody levels dropped in both the
treated and untreated group and the differences only be-
came clear after >6 months, when the anti-O. ostertagi
antibody levels started to rise again. The concurrent
drop in both the treated and untreated group may be ex-
plained by a dilution effect since milk production is
highest 2–3 months following treatment. However, this
effect has previously been estimated to be small [25]. A
second possible reason is a generally lower exposure to
GI nematodes in the herd caused by treatment approxi-



















Figure 3 Average lactation curve of cows treated with eprinomectin aThere was a considerable variation in treatment response
between the different herds. In one herd, there was a sig-
nificant negative effect of treatment on milk production.
Interestingly, although the animals were grazed up to the
start of the trial, further investigation revealed that the ani-
mals in this herd had not been at pasture during the entire
study period. This, together with the low average (± stand-
ard deviation) bulk tank milk O. ostertagi ELISA results
(0.52 ODR (±0.09)) suggests a very low worm exposure in
this herd. When this herd was excluded from the analysis,
the overall treatment effect (95% confidence interval) on
milk yield was 1.09 (0.42 – 1.76) kg milk per day per cow.
Currently, targeted selective treatments (TST), where
anthelmintic treatments are given to selected individuals200 300
ilk
t calving versus untreated cows.
















































( average kg milk / day per cow with 95% confidence interval)
Figure 4 Estimated effect of eprinomectin treatment at calving on daily milk yield (kg) per cow according to different potential
selection parameters for anthelmintic treatment. Error bars represent the 95%-confidence interval. Categories for body condition score and
O. ostertagi ELISA are based on quartiles.
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animal performance whilst reducing the selection of an-
thelmintic resistant nematodes [2]. However, until now,
TST have been mostly evaluated in sheep [26-31] and
few data are available to determine which parameters
are useful in identifying cattle that would benefit most
from anthelmintic treatment. Previously the anti-O.
ostertagi antibody level in individual milk samples has
been proposed as a useful indicator of which animals
would benefit most from treatment [3,11,12,16]. Here,
















Figure 5 Relationship between faecal egg count results and
daily milk yield (kg) per cow measured at two herds. The dotted
lines represent the standard error of the mean.observed in the cows with the highest anti-O. ostertagi
antibody level. However, considerable responses were
also observed in animals with low anti-O. ostertagi
antibody levels, which corresponds to a recent study of
Ravinet et al. [8]. This indicates that significant eco-
nomic potential may be lost if only animals with a high
anti-O. ostertagi antibody level are treated and highlights
the need to assess the broader economic implications
on-farm when this indicator would be used as the prin-
cipal treatment criterion.
In addition to the anti-O. ostertagi antibody level, we
identified 2 other promising candidates for targeting indi-
vidual treatments: age and FEC. Although higher treatment
responses in older cattle may appear counterintuitive, as
these animals are considered to be functionally immune to
gastrointestinal nematodes, several previous studies re-
ported higher treatment responses with increasing cow age
[3,13,25]. As discussed before [3], the latter may be attrib-
uted to a different priority of nutrient allocation between
primi- and multiparous cows [13] or the higher energy re-
quirements of the immune response to GI nematodes in
older animals, as observed in sheep [32]. Finally, it may also
be considered that the level of GI nematode infection in
primiparous cows is generally lower than in older cows. A
recent survey in Europe showed that anthelmintic control
measures in young stock are relatively intensive resulting
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a compromised build-up of immunity against these
parasites [33].
The milk production response increased in those ani-
mals with higher FECs at calving. This is surprising be-
cause FECs are generally considered as a poor indicator
of the GI nematode infection level in cattle [34,35].
O’Farrell et al. [17] and Walsh et al. [36] found no rela-
tionship between milk yield response after anthelmintic
treatment and FEC. However, in a recent study, a signifi-
cantly lower milk production was observed in animals
with a FEC >10 EPG, although whether these animals
would also have a higher milk yield after anthelmintic
treatment was not investigated [37]. Our results require
to be confirmed because they are only based on observa-
tions in 2 herds. A possible reason why we observe this
relationship is because a much more sensitive technique
(FLOTAC with analytical sensitivity of 2 EPG) was used
than in the previous studies.
A significant positive treatment effect on milk produc-
tion was found for cows with a BCS between the 25th and
50th percentile. Despite our attempt to standardize this
variable by centering it to the herd mean, the results for
the BCS should still be interpreted with caution since im-
portant between-farmer variability may remain present and
the study design did not take BCS into account as blocking
parameter. Based on the described relationship between
BCS around calving and subsequent milk yield [38], it
could be expected that production responses are lower in
cows with either a very low or very high BCS. Such a rela-
tionship was previously observed in a study investigating
milk yield responses after flukicide treatments [9].
Conclusions
In conclusion, this randomized controlled field trial dem-
onstrates that eprinomectin treatment at calving reduces
the infection levels with gastro-intestinal nematodes and
increases the daily milk yield in the following lactation.
Treatment responses were highest in animals in their third
or higher lactation, with a high pre-treatment anti-O.
ostertagi antibody level in a milk sample of the previous
lactation and in animals with a moderate body condition
score. Further research needs to be done to assess the eco-
nomic impact of selective treatment approaches, which
greatly influences the eventual uptake of these indicators
in practice.
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